Cargando…
Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273723/ https://www.ncbi.nlm.nih.gov/pubmed/37322553 http://dx.doi.org/10.1186/s13054-023-04528-0 |
| _version_ | 1785059703427956736 |
|---|---|
| author | Kotani, Yuki Pruna, Alessandro Lee, Todd C. Roth, Dominik Landoni, Giovanni |
| author_facet | Kotani, Yuki Pruna, Alessandro Lee, Todd C. Roth, Dominik Landoni, Giovanni |
| author_sort | Kotani, Yuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10273723 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102737232023-06-17 Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply Kotani, Yuki Pruna, Alessandro Lee, Todd C. Roth, Dominik Landoni, Giovanni Crit Care Correspondence BioMed Central 2023-06-15 /pmc/articles/PMC10273723/ /pubmed/37322553 http://dx.doi.org/10.1186/s13054-023-04528-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correspondence Kotani, Yuki Pruna, Alessandro Lee, Todd C. Roth, Dominik Landoni, Giovanni Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title | Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title_full | Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title_fullStr | Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title_full_unstemmed | Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title_short | Comment to: “Propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| title_sort | comment to: “propofol and survival: an updated meta-analysis of randomized clinical trials”: authors’ reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273723/ https://www.ncbi.nlm.nih.gov/pubmed/37322553 http://dx.doi.org/10.1186/s13054-023-04528-0 |
| work_keys_str_mv | AT kotaniyuki commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrialsauthorsreply AT prunaalessandro commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrialsauthorsreply AT leetoddc commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrialsauthorsreply AT rothdominik commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrialsauthorsreply AT landonigiovanni commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrialsauthorsreply |